Julia Dembowska
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Julia Dembowska has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Ada Świątko
Voivodeship Specialist Hospital in Wroclaw : Wroclaw, Lower Silesia, Poland
1 shared publication - Aleksandra Banaszczyk
Students Scientific Society of Microbiologists, association at The Department of Microbiology, Faculty of Medicine, Wroclaw Medical University Wroclaw
1 shared publication - Ewelina Lachowska
Provincial Specialist Hospital in Wrocław
1 shared publication - Joanna Nowicka
Department of Microbiology, Faculty of Medicine, Wroclaw Medical University, Chalubinskiego 4, 50-368 Wroclaw, Poland
1 shared publication - Magdalena Pajączkowska
Department of Microbiology, Faculty of Medicine, Wroclaw Medical University, Chalubinskiego 4, 50-368 Wroclaw, Poland
1 shared publication - Mateusz Chmiela
Health Care Center in Olawa
1 shared publication
Latest Publications
- Open Access
- 27 June 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 60
Cholinergic Urticaria - Clinical Significance in Athletes and Physically Active Individuals: A Narrative Review
Introduction. Cholinergic urticaria (CholU) is a subtype of chronic inducible urticaria triggered by increases in core body temperature and sweating. Its trigger profile, encompassing exercise, passive warming, emotional stress, and hot environments, renders it particularly relevant to athletes and physically active individuals, in whom these stimuli are frequent and often unavoidable. Purpose. This narrative review aimed to summarize current evidence on the clinical significance, diagnostic challenges, differential diagnosis, and practical management of cholinergic urticaria in athletes and physically active populations. Current knowledge. CholU predominantly affects young adults and involves heterogeneous pathophysiological mechanisms, including mast cell activation, sweat hypersensitivity, and acetylcholine-mediated pathways. In athletes, recurrent symptoms such as wheals, pruritus, and burning sensations may interrupt training, reduce exercise tolerance, and impair psychological well-being. Diagnosis relies on provocation testing, while differential diagnosis must exclude exercise-induced anaphylaxis, food-dependent exercise-induced anaphylaxis, and other inducible urticarias. Management centers on second-generation antihistamines, trigger modification, and, in refractory cases, omalizumab, which has enabled some patients to resume full athletic participation. Conclusions. CholU poses a distinct and underrecognized burden in physically active individuals. Individualized management combining pharmacotherapy with exercise modification can allow most patients to maintain safe participation in physical activity, though further research is needed to optimize treatment strategies.
- 27 June 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 60
Open AccessCholinergic Urticaria - Clinical Significance in Athletes and Physically Active Individuals: A Narrative Review
Introduction. Cholinergic urticaria (CholU) is a subtype of chronic inducible urticaria triggered by increases in core body temperature and sweating. Its trigger profile, encompassing exercise, passive warming, emotional stress, and hot environments, renders it particularly relevant to athletes and physically active individuals, in whom these stimuli are frequent and often unavoidable. Purpose. This narrative review aimed to summarize current evidence on the clinical significance, diagnostic challenges, differential diagnosis, and practical management of cholinergic urticaria in athletes and physically active populations. Current knowledge. CholU predominantly affects young adults and involves heterogeneous pathophysiological mechanisms, including mast cell activation, sweat hypersensitivity, and acetylcholine-mediated pathways. In athletes, recurrent symptoms such as wheals, pruritus, and burning sensations may interrupt training, reduce exercise tolerance, and impair psychological well-being. Diagnosis relies on provocation testing, while differential diagnosis must exclude exercise-induced anaphylaxis, food-dependent exercise-induced anaphylaxis, and other inducible urticarias. Management centers on second-generation antihistamines, trigger modification, and, in refractory cases, omalizumab, which has enabled some patients to resume full athletic participation. Conclusions. CholU poses a distinct and underrecognized burden in physically active individuals. Individualized management combining pharmacotherapy with exercise modification can allow most patients to maintain safe participation in physical activity, though further research is needed to optimize treatment strategies.
- Open Access
- 1 December 2025
- Published by Walter de Gruyter GmbH in Advancements of Microbiology
- Vol. 64 (4) , 251-269
Antimicrobial Peptides as an Alternative Treatment for Oral Cavity Infections?
The ability of microorganisms to form biofilm structures is at the root of many diseases of the oral cavity. Biofilm – in particular its abnormal growth in combination with other factors, such as impaired functioning of specific and non-specific defence mechanisms of the human body or disorders in the quantitative and qualitative composition of the oral microbiota – may lead to the development of caries, gingivitis or periodontitis. Treatment of this type of infections is a challenge for modern dentistry, also due to the increasing resistance of microorganisms. The above requires a search for alternative therapeutic methods. This paper presents a general characteristics of antimicrobial peptides, briefly characterizes oral diseases and provides basic information on infection therapy in dentistry. It also discusses the possibilities of therapeutic use of natural and synthetic antimicrobial peptides in dentistry.
- 1 December 2025
- Published by Walter de Gruyter GmbH in Advancements of Microbiology
- Vol. 64 (4) , 251-269
Open AccessAntimicrobial Peptides as an Alternative Treatment for Oral Cavity Infections?
The ability of microorganisms to form biofilm structures is at the root of many diseases of the oral cavity. Biofilm – in particular its abnormal growth in combination with other factors, such as impaired functioning of specific and non-specific defence mechanisms of the human body or disorders in the quantitative and qualitative composition of the oral microbiota – may lead to the development of caries, gingivitis or periodontitis. Treatment of this type of infections is a challenge for modern dentistry, also due to the increasing resistance of microorganisms. The above requires a search for alternative therapeutic methods. This paper presents a general characteristics of antimicrobial peptides, briefly characterizes oral diseases and provides basic information on infection therapy in dentistry. It also discusses the possibilities of therapeutic use of natural and synthetic antimicrobial peptides in dentistry.